[
    {
        "answer_full": "2017",
        "supporting_text": null,
        "country": "myanmar",
        "question": "period_start"
    },
    {
        "answer_full": "2022",
        "supporting_text": null,
        "country": "myanmar",
        "question": "period_end"
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP mentions a National One Health Strategy which identifies AMR as a priority.",
        "country": "myanmar",
        "question": 1
    },
    {
        "answer_full": "yes",
        "supporting_text": "Objective 3.2: Decrease Hospital Acquired Infection (HAI) and associated AMR through facility based HAI surveillance programme (Human Health).",
        "country": "myanmar",
        "question": 2
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes actions related to animal health, such as the establishment of a National Drug Regulatory Authority (NDRA) for veterinary sector.",
        "country": "myanmar",
        "question": 3
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP mentions the need for environmental surveillance for AMR as part of the overall strategy.",
        "country": "myanmar",
        "question": 4
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes objectives related to optimizing antimicrobial use in agriculture and food production sectors.",
        "country": "myanmar",
        "question": 5
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NACC will report implementation status to NMSC, national agencies and international partners.",
        "country": "myanmar",
        "question": 6
    },
    {
        "answer_full": "yes",
        "supporting_text": "By 2022, the country would have carried out nationwide evidence-based awareness campaigns with regular Monitoring and Evaluation (M&E).",
        "country": "myanmar",
        "question": 7
    },
    {
        "answer_full": "no",
        "supporting_text": "The document does not specify quantitative targets for AMR prevalence and antimicrobial use.",
        "country": "myanmar",
        "question": 8
    },
    {
        "answer_full": "no",
        "supporting_text": "Detailed planning along with the budget allotted for the respective activities will be done in due course by national stakeholders.",
        "country": "myanmar",
        "question": 9
    },
    {
        "answer_full": "no",
        "supporting_text": "The document does not contain an assessment of future budget requirements.",
        "country": "myanmar",
        "question": 10
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP establishes a National Multi-Sectoral Steering Committee (NMSC) for Antimicrobial Resistance.",
        "country": "myanmar",
        "question": 11
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes the establishment of a National Drug Policy with special reference to AMAs and AMR.",
        "country": "myanmar",
        "question": 12
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP aims to revise curricula in undergraduate medical and veterinary, food industry and agriculture teaching.",
        "country": "myanmar",
        "question": 13
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes plans for nationwide evidence-based awareness campaigns targeting various audiences.",
        "country": "myanmar",
        "question": 14
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP mentions collaboration with WHO, FAO, and OIE for technical support and implementation.",
        "country": "myanmar",
        "question": 15
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes the establishment of a national AMR surveillance system and coordination structure.",
        "country": "myanmar",
        "question": 16
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP aims to develop a One Health AMR surveillance plan in humans, animals, and food.",
        "country": "myanmar",
        "question": 17
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes objectives related to hygiene, infection prevention, and control measures.",
        "country": "myanmar",
        "question": 18
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP mentions the need to develop guidelines for AMR surveillance incorporating international standards.",
        "country": "myanmar",
        "question": 19
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes the development of an essential medicines list with special reference to the use of antimicrobial agents.",
        "country": "myanmar",
        "question": 20
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP includes the establishment of a regulatory framework for control of human and veterinary use of antimicrobial substances.",
        "country": "myanmar",
        "question": 21
    },
    {
        "answer_full": "yes",
        "supporting_text": "The NAP envisions collaborations with national and international agencies for implementation of strategic research agenda.",
        "country": "myanmar",
        "question": 22
    }
]